Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Feldman

Showing results (261-270 of 262) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 262 results.
The American Journal of Cardiology|March 16, 2001
Results of the study to determine rotablator and transluminal angioplasty strategy (STRATAS)P L Whitlow, T A Bass, R M Kipperman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2021
The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphomaS Horwitz, O A O'Connor, B Pro, et al.
Pageof 27

Showing results (261-270 of 262) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 262 results.
The American Journal of Cardiology|March 16, 2001
Results of the study to determine rotablator and transluminal angioplasty strategy (STRATAS)P L Whitlow, T A Bass, R M Kipperman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2021
The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphomaS Horwitz, O A O'Connor, B Pro, et al.
Pageof 27